TSS
SRPT icon

Two Sigma Securities’s Sarepta Therapeutics SRPT Stock Holding History

Two Sigma Securities’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,100
Closed -$529K – 1663
2020
Q4 		$529K Buy
+3,100
New +$459K 0.01% 661
2020
Q1 		– Sell
-5,700
Closed -$736K – 2230
2019
Q4 		$736K Buy
+5,700
New +$575K 0.01% 1221

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Two Sigma Securities's SRPT Position: Q2 2025 in Review

Two Sigma Securities sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 5,980 shares — an estimated $382K sold.

Two Sigma Securities first reported a position in SRPT in Q2 2017 and held it in 6 quarters. The position peaked at $959K in Q4 2019. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • Two Sigma Securities reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 5,980 Sarepta Therapeutics shares in Q2 2025, an estimated $382K.
  • Two Sigma Securities first reported a position in Sarepta Therapeutics in Q2 2017 and held it in 6 quarters.
  • Two Sigma Securities's Sarepta Therapeutics position peaked at $959K in Q4 2019.
  • 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.